These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10414702)

  • 21. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
    Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
    Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India.
    Gaur D; Arora S; Mathur M; Nath N; Chattopadhaya TK; Ralhan R
    Clin Cancer Res; 1997 Nov; 3(11):2129-36. PubMed ID: 9815606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of p53/BAX/p16(ink4a/CDKN2) in esophageal squamous cell carcinoma: high BAX and p16(ink4a/CDKN2) identifies patients with good prognosis.
    Sturm I; Petrowsky H; Volz R; Lorenz M; Radetzki S; Hillebrand T; Wolff G; Hauptmann S; Dörken B; Daniel PT
    J Clin Oncol; 2001 Apr; 19(8):2272-81. PubMed ID: 11304781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STMN-1 gene: a predictor of survival in stage iia esophageal squamous cell carcinoma after Ivor-Lewis esophagectomy?
    Akhtar J; Wang Z; Yu C; Zhang ZP; Bi MM
    Ann Surg Oncol; 2014 Jan; 21(1):315-21. PubMed ID: 23975322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 mutation as a prognostic marker in advanced laryngeal carcinoma. Department of Veterans Affairs Laryngeal Cancer Cooperative Study Group.
    Bradford CR; Zhu S; Poore J; Fisher SG; Beals TF; Thoraval D; Hanash SM; Carey TE; Wolf GT
    Arch Otolaryngol Head Neck Surg; 1997 Jun; 123(6):605-9. PubMed ID: 9193221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognosis of esophageal squamous cell carcinoma: analysis of clinicopathological and biological factors.
    Wang LS; Chow KC; Chi KH; Liu CC; Li WY; Chiu JH; Huang MH
    Am J Gastroenterol; 1999 Jul; 94(7):1933-40. PubMed ID: 10406262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significance of p53 expression as a prognostic factor in oesophageal squamous cell carcinoma.
    Shimaya K; Shiozaki H; Inoue M; Tahara H; Monden T; Shimano T; Mori T
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(4):271-6. PubMed ID: 8506620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of human papillomavirus DNA and p53 gene mutations in esophageal cancer samples and adjacent normal mucosa.
    Astori G; Merluzzi S; Arzese A; Brosolo P; de Pretis G; Maieron R; Pipan C; Botta GA
    Digestion; 2001; 64(1):9-14. PubMed ID: 11549832
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of p53 in esophageal squamous cell carcinoma and the correlation with survival: analyses of gene mutations, protein expression, and loss of heterozygosity in Japanese patients.
    Egashira A; Morita M; Yoshida R; Saeki H; Oki E; Sadanaga N; Kakeji Y; Tsujitani S; Maehara Y
    J Surg Oncol; 2011 Aug; 104(2):169-75. PubMed ID: 21462189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No prognostic significance of p53 expression in esophageal squamous cell carcinoma.
    Kanamoto A; Kato H; Tachimori Y; Watanabe H; Nakanishi Y; Kondo H; Yamaguchi H; Gotoda T; Muro K; Matsumura Y
    J Surg Oncol; 1999 Oct; 72(2):94-8. PubMed ID: 10518106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of p53 mutations and the expression of p53 and p21WAF1/CIP1 protein in 15 cases of sebaceous carcinoma of the eyelid.
    Kiyosaki K; Nakada C; Hijiya N; Tsukamoto Y; Matsuura K; Nakatsuka K; Daa T; Yokoyama S; Imaizumi M; Moriyama M
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):7-11. PubMed ID: 19628749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
    Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 mutation profiling of multiple esophageal carcinoma using laser capture microdissection to demonstrate field carcinogenesis.
    Ito S; Ohga T; Saeki H; Nakamura T; Watanabe M; Tanaka S; Kakeji Y; Maehara Y
    Int J Cancer; 2005 Jan; 113(1):22-8. PubMed ID: 15386362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alterations of p53 gene and Ha-ras gene are independent events in solar keratosis and squamous cell carcinoma.
    Taguchi M; Tsuchida T; Ikeda S; Sekiya T
    Pathol Int; 1998 Sep; 48(9):689-94. PubMed ID: 9778107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.
    Sisk EA; Soltys SG; Zhu S; Fisher SG; Carey TE; Bradford CR
    Head Neck; 2002 Sep; 24(9):841-9. PubMed ID: 12211048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the 7th edition of the TNM classification in patients with resected esophageal squamous cell carcinoma.
    Wang J; Wu N; Zheng QF; Yan S; Lv C; Li SL; Yang Y
    World J Gastroenterol; 2014 Dec; 20(48):18397-403. PubMed ID: 25561808
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific intronic p53 mutation in esophageal squamous cell carcinoma in Southern Thailand.
    Thongsuksai P; Boonyaphiphat P; Puttawibul P; Sudhikaran W
    World J Gastroenterol; 2010 Nov; 16(42):5359-66. PubMed ID: 21072901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.